EXMceuticals has collaboration agreements with universities in Portugal to create multi-university decentralized research teams, each focusing on specific aspects of a research project. Internships will be created, providing university students with hands-on experience in agriculture, extraction processes, laboratory work as well as micropropagation and crop management, in their country of origin and abroad.
EXMceuticals will focus on research projects in a number of areas:
- Agriculture -- maximizing yields while using 100% natural solutions for pest control and achieving 100% organic certification
- Extraction processes -- using 100% natural processes
- The use of cannabinoid ingredients in pharmaceutical, nutraceutical and therapeutical products and clinical trials in this research
EXMceuticals has agreements with these three universities in Portugal:
NOVA University of Lisbon
Founded in 1973, it is the youngest of the public universities in the Portuguese capital city, earning its name as the “New” (NOVA) University of Lisbon.
This Institution has more than 19,000 students, 1,491 Professors and 804 staff. NOVA is recognized as one of the world’s best universities having being ranked number 312 in the world by Times Higher Education in 2014.
NOVA University of Lisbon acts as the legal front institution of multiple research units, from different scientific fields, carrying out research work and managing financial and administratively R&D projects for Universidade Nova de Lisboa.
NOVA.ID.FCT promotes and facilitates scientific research, technology and development services to society. As well, NOVA.ID.FCT organizes qualified human resources training and consulting expertise and knowledge dissemination and technology transfer.
Universidade Lusófona de Humanidades e Tecnologias
Lusophone University of Humanities and Technologies is the largest private Portuguese university and the main institution of Grupo Lusófona. Lusophone University administers other universities and colleges in Portugal, Brazil, Cape Verde, Angola, Guinea-Bissau and Mozambique.
EXMceuticals has entered into a Memorandum of Understanding with GFR Pharma Inc (gfrpharma.com).
Under this Memorandum of Understanding we are establishing a joint venture company which will file to obtain a license from Health Canada, to import and distribute cannabinoid ingredients, as well as produce white label retail products containing cannabinoid ingredients, through GFR Pharma facilities:
GFR Pharma is a pre-eminent full-service contract manufacturer, packager and formulation expert of superior quality tablet, capsule, powder, and liquid natural health products for the Canadian, U.S. and international markets.